Troy E. Wilson - Jul 14, 2022 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role
President and CEO, Director
Signature
Teresa Bair, attorney-in-fact for Troy E. Wilson
Stock symbol
KURA
Transactions as of
Jul 14, 2022
Transactions value $
$0
Form type
4
Date filed
2/21/2023, 04:04 PM
Previous filing
Jun 21, 2022
Next filing
Jun 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KURA Common Stock Other $0 -468K -28.91% $0.00 1.15M Jul 14, 2022 by Red Fish Blue Fish Revocable Trust F1
transaction KURA Common Stock Other $0 -17.7K -1.54% $0.00 1.13M Aug 19, 2022 by Red Fish Blue Fish Revocable Trust F1
transaction KURA Common Stock Other $0 -41.3K -3.64% $0.00 1.09M Aug 19, 2022 by Red Fish Blue Fish Revocable Trust F2
transaction KURA Common Stock Other $0 +41.3K $0.00 41.3K Aug 19, 2022 by One Fish Two Fish Revocable Trust F2
transaction KURA Common Stock Other $0 -1.08M -99.23% $0.00 8.39K Oct 6, 2022 by Red Fish Blue Fish Revocable Trust F2
transaction KURA Common Stock Other $0 +1.08M +2624.28% $0.00 1.13M Oct 6, 2022 by One Fish Two Fish Revocable Trust F2
transaction KURA Common Stock Other $0 -12K -28.19% $0.00 30.5K Aug 19, 2022 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KURA Option to purchase common stock Award $0 +560K $0.00 560K Feb 16, 2023 Common Stock 560K $11.99 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were transferred to the reporting person's former spouse pursuant to a divorce settlement. The securities owned by the former spouse are not beneficially owned by the reporting person.
F2 This transaction represents a transfer of shares of common stock without consideration from a grantor trust established by the reporting person to another grantor trust established by the reporting person.
F3 Includes 1,109 shares acquired on November 17, 2021 and 1,450 shares acquired on May 17, 2022 pursuant to the Issuer's Employee Stock Purchase Plan.
F4 This option vests in 48 equal monthly installments commencing on the grant date.